ESR and IgG Fluctuations in Ankylosing Spondylitis Treatment - Internal Medicine

More Info

---

In patients with Ankylosing Spondylitis (AS), fluctuations in inflammatory markers such as Erythrocyte Sedimentation Rate (ESR) and Immunoglobulin G (IgG) can be indicative of underlying disease activity or response to treatment. Your experience of having a significant increase in ESR and IgG levels after starting biological therapy is indeed concerning and warrants further investigation.

ESR is a non-specific marker of inflammation, meaning it can be elevated in various conditions, not just in AS. An increase in ESR often indicates an active inflammatory process in the body. In the context of AS, elevated ESR levels can suggest that the disease is not fully controlled, or that there may be an exacerbation of symptoms. The fact that your ESR levels rose from 52 to 71 within a couple of months, despite being on a biological agent, suggests that there may be ongoing inflammation that is not being adequately managed by the current treatment regimen.

IgG, on the other hand, is a type of antibody that can be elevated in response to infections, autoimmune diseases, or chronic inflammatory conditions. The rise in IgG levels from 1756 to 2345 could indicate an immune response to an underlying infection or a flare in your autoimmune condition. It is important to note that elevated IgG levels can also occur in other conditions, including chronic infections and certain malignancies, so it is crucial to interpret these results in the context of your overall clinical picture.

Given your history of AS and the recent changes in your laboratory results, it is essential to consider several factors:
1. Disease Activity: The increase in ESR and IgG may indicate that your AS is more active than previously thought. This could be due to inadequate response to the biological therapy or the development of new inflammatory processes.

2. Infection: Elevated ESR and IgG can also be a sign of infection. It would be prudent to rule out any infections, particularly since biological therapies can increase susceptibility to infections.

3. Other Autoimmune Conditions: Sometimes, patients with one autoimmune disease may develop another. It is worth discussing with your healthcare provider whether further testing for other autoimmune conditions is warranted.

4. Medication Review: It may be beneficial to review your current medications with your rheumatologist. Adjustments to your treatment plan, including the possibility of changing the biological agent or adding other medications, may be necessary to better control your symptoms and inflammatory markers.

5. Symptom Monitoring: Pay attention to any new or worsening symptoms, such as increased pain, stiffness, fatigue, or systemic symptoms like fever or weight loss. These could provide additional clues about your condition.

In conclusion, the significant fluctuations in your ESR and IgG levels are concerning and should be discussed with your rheumatologist. They may recommend further testing, including imaging studies or additional blood tests, to assess for active inflammation or other underlying conditions. Close monitoring and a tailored treatment approach are essential in managing Ankylosing Spondylitis effectively.